Molecule shown to produce cognitive improvement in rodents with early Alzheimer's disease
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...
Dementia Cases in the U.S. Expected to Double by 2060, Hitting 1 Million a Year
Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.
Monthly Prescribing Reference6 小时
Lecanemab SC Formulation Under Review for Early Alzheimer Disease
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi ...
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...
New study shows risk of developing dementia in the U.S. is much higher than previously ...
People in the United States are living longer and with that comes increased rates of dementia. Dr. Josef Coresh, with NYU ...